Blue Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$187K Sell
2,503
-227
-8% -$18K ﹤0.01% 789
2026
Q2
$216K Buy
2,730
+245
+10% +$20.8K ﹤0.01% 763
2026
Q1
$214K Buy
+2,485
New +$223K ﹤0.01% 752
2024
Q4
– Sell
-216
Closed -$14.8K – 2651
2024
Q3
$14.8K Buy
216
+61
+39% +$4.31K ﹤0.01% 2062
2024
Q2
$8.31K Buy
155
+18
+13% +$1.08K ﹤0.01% 2004
2024
Q1
$7.35K Buy
137
+30
+28% +$1.61K ﹤0.01% 1535
2023
Q4
$5K Sell
107
-55
-34% -$2.68K ﹤0.01% 1834
2023
Q3
$10K Buy
162
+73
+82% +$4.08K ﹤0.01% 1408
2023
Q2
$5K Sell
89
-437
-83% -$24.9K ﹤0.01% 1526
2023
Q1
$39K Buy
526
+76
+17% +$4.87K ﹤0.01% 1124
2022
Q4
$27K Buy
450
+277
+160% +$18.9K ﹤0.01% 1175
2022
Q3
$10K Buy
173
+59
+52% +$3.55K ﹤0.01% 1332
2022
Q2
$8K Buy
+114
New +$7.49K ﹤0.01% 1280

Other funds holding GMED

Blue Trust's GMED Position: Q3 2026 in Review

Blue Trust reduced its Globus Medical (GMED) stake by 8.3% in Q3 2026, selling an estimated $18K and leaving 2,503 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Blue Trust first reported a position in GMED in Q2 2022 and has held it in 13 quarters since. The position peaked at $216K in Q2 2026. 521 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Blue Trust held 2,503 shares of Globus Medical worth $187K as of Q3 2026.
  • Blue Trust sold 227 Globus Medical shares in Q3 2026, an estimated $18K.
  • Globus Medical made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #789 holding.
  • Blue Trust first reported a position in Globus Medical in Q2 2022 and has held it in 13 quarters since.
  • Blue Trust's Globus Medical position peaked at $216K in Q2 2026.
  • 521 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.